Vikash Tatayah had by no means heard of Colossal Biosciences till the Texas-based firm introduced plans final yr to carry again the dodo. Broadly recognized for eager to “de-extinct” the woolly mammoth, it mentioned it was making strides within the genetic engineering of dodo-like birds, which might then be delivered to Mauritius, one of many Indian Ocean’s Mascarene islands and the dodo’s sole habitat earlier than extinction.
As conservation director on the Mauritian Wildlife Basis, Tatayah had labored for many years to preserve the nation’s surviving endemic species, from the Mauritius fruit bat to the pink pigeon, a dodo relative. So he was stunned that his organisation wasn’t within the loop – and considerably sceptical of the motives behind the multi-million-dollar challenge. “I was the first to say, ‘Hold on. There are a lot of other species of plants and animals on Mauritius that are threatened. That money could be better spent.’”
Whether or not genetic engineering needs to be used for conservation stays contentious, and lots of are particularly cautious of de-extinction. However a yr later, Tatayah sees the potential return of the dodo as a method to concurrently rescue endangered species – particularly the pink pigeon. “We are very keen for the dodo to be brought back,” he says.
Typically ignored is that the biotech breakthroughs Colossal and others are engaged on may have necessary collateral advantages. They might clear a path to utilizing genetic instruments to shortly assist an entire vary of animals resist the pressures they face from a altering surroundings. “The tempo of change is quicker than evolution by pure…
